178 related articles for article (PubMed ID: 12624744)
1. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).
Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G
Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744
[TBL] [Abstract][Full Text] [Related]
2. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II).
Cheon MS; Bajo M; Kim SH; Claudio JO; Stewart AK; Patterson D; Kruger WD; Kondoh H; Lubec G
Amino Acids; 2003; 24(1-2):119-25. PubMed ID: 12624743
[TBL] [Abstract][Full Text] [Related]
3. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).
Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G
Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742
[TBL] [Abstract][Full Text] [Related]
4. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part IV).
Cheon MS; Shim KS; Kim SH; Hara A; Lubec G
Amino Acids; 2003 Jul; 25(1):41-7. PubMed ID: 12836057
[TBL] [Abstract][Full Text] [Related]
5. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
6. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
Rachidi M; Lopes C
Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
[TBL] [Abstract][Full Text] [Related]
7. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
Cheon MS; Dierssen M; Kim SH; Lubec G
Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
[TBL] [Abstract][Full Text] [Related]
8. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down Syndrome.
Greber-Platzer S; Schatzmann-Turhani D; Wollenek G; Lubec G
Biochem Biophys Res Commun; 1999 Jan; 254(2):395-9. PubMed ID: 9918849
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling in the adult Down syndrome brain.
Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
[TBL] [Abstract][Full Text] [Related]
10. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
Rachidi M; Lopes C
Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
[TBL] [Abstract][Full Text] [Related]
11. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.
Pritchard MA; Kola I
J Neural Transm Suppl; 1999; 57():293-303. PubMed ID: 10666684
[TBL] [Abstract][Full Text] [Related]
12. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
13. Protein levels of genes encoded on chromosome 21 in fetal Down Syndrome brain (Part V): overexpression of phosphatidyl-inositol-glycan class P protein (DSCR5).
Ferrando-Miguel R; Cheon MS; Lubec G
Amino Acids; 2004 Jun; 26(3):255-61. PubMed ID: 15221505
[TBL] [Abstract][Full Text] [Related]
14. Expression of trisomic proteins in Down syndrome model systems.
Spellman C; Ahmed MM; Dubach D; Gardiner KJ
Gene; 2013 Jan; 512(2):219-25. PubMed ID: 23103828
[TBL] [Abstract][Full Text] [Related]
15. Genetic mechanisms involved in the phenotype of Down syndrome.
Patterson D
Ment Retard Dev Disabil Res Rev; 2007; 13(3):199-206. PubMed ID: 17910086
[TBL] [Abstract][Full Text] [Related]
16. [Screening and identification of human chromosome 21 genes resulting in abnormal development of fetal cerebral cortex with Down syndrome].
Yu WD; Liang R; Yang LJ; Shang M; Shen H; Guan J; Guo JZ
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2759-63. PubMed ID: 18167266
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21).
Peyrl A; Weitzdoerfer R; Gulesserian T; Fountoulakis M; Lubec G
Electrophoresis; 2002 Jan; 23(1):152-7. PubMed ID: 11824616
[TBL] [Abstract][Full Text] [Related]
18. Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brain.
Shim KS; Bergelson JM; Furuse M; Ovod V; Krude T; Lubec G
J Neural Transm Suppl; 2003; (67):117-28. PubMed ID: 15068244
[TBL] [Abstract][Full Text] [Related]
19. Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: an in vitro model of Down syndrome.
Kadota M; Nishigaki R; Wang CC; Toda T; Shirayoshi Y; Inoue T; Gojobori T; Ikeo K; Rogers MS; Oshimura M
Neuroscience; 2004; 129(2):325-35. PubMed ID: 15501590
[TBL] [Abstract][Full Text] [Related]
20. AgNOR status in Down's syndrome infants and a plausible phenotype formation hypothesis.
Demirtas H
Micron; 2009; 40(5-6):511-8. PubMed ID: 19339189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]